Free 7-day Trial
All Articles and Columns »

NAVIDEA BIOPHARMACEUTICALS INC. (NAVB) CEO Mark Jerome Pykett buys 1,850 Shares

March 18, 2013 | About:
insider

insider

52 followers
Pres. & CEO of NAVIDEA BIOPHARMACEUTICALS INC. (NAVB) Mark Jerome Pykett buys 1,850 shares of NAVB on 03/15/2013 at an average price of $2.7 a share.

Navidea Biopharmaceuticals Inc has a market cap of $303 million; its shares were traded at around $2.82 with and P/S ratio of 3520.7.

This is the annual revenues and earnings per share of NAVB over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of NAVB.


CEO Recent Trades:



  • Pres. & CEO Mark Jerome Pykett bought 1,850 shares of NAVB stock on 03/15/2013 at the average price of 2.7. Mark Jerome Pykett owns at least 358,212 shares after this. The price of the stock has increased by 4.44% since.

This is the insider trade history vs. stock price of NAVB. For the complete insider trading history of NAVB, click here.




Directors and Officers Recent Trades:



  • Director Brendan A Ford bought 5,000 shares of NAVB stock on 03/15/2013 at the average price of 2.71. Brendan A Ford owns at least 119,250 shares after this. The price of the stock has increased by 4.06% since.
  • SVP-Global Regulatory Strategy William J. Regan bought 5,000 shares of NAVB stock on 03/15/2013 at the average price of 2.71. William J. Regan owns at least 5,000 shares after this. The price of the stock has increased by 4.06% since.
  • EVP & Chief Business Officer Thomas H. Tulip bought 17,500 shares of NAVB stock on 03/15/2013 at the average price of 2.82. Thomas H. Tulip owns at least 45,940 shares after this. The price of the stock has decreased by 0% since.
  • Director Gordon A Troup bought 7,000 shares of NAVB stock on 03/15/2013 at the average price of 2.7. Gordon A Troup owns at least 126,250 shares after this. The price of the stock has increased by 4.44% since.
  • 10% Owner Life Sciences Platinum-montaur sold 708,382 shares of NAVB stock on 09/21/2012 at the average price of 3.7. Life Sciences Platinum-montaur owns at least 6,801,016 shares after this. The price of the stock has decreased by 23.78% since.


For the complete insider trading history of NAVB, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 4.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide